Sign up
Log in
Why Petco Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Share
Listen to the news

Shares of Petco Health and Wellness Company Inc (NASDAQ:WOOF) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter sales results.

Petco Health and Wellness reported quarterly losses of 1 cent per share which missed the Street estimate of for earnings of 2 cents. Quarterly revenue clocked in at $1.515 billion which beat the analyst consensus of $1.513 billion.

Petco Health and Wellness shares jumped 12.1% to $2.69 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • Tillys Inc (NYSE:TLYS) gained 53.5% to $2.50 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter sales guidance above estimates.
  • Laird Superfood Inc (NYSE:LSF) gained 35.1% to $3.35 in pre-market trading. Laird Superfood will report fourth quarter and fiscal year 2025 financial results on March 26.
  • Codexis Inc (NASDAQ:CDXS) surged 33.8% to $1.70 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY26 sales guidance above estimates.
  • Turbo Energy SA (NASDAQ:TURB) gained 28.3% to $4.80 in pre-market trading after adding around 8% on Wednesday.
  • Wellgistics Health Inc (NASDAQ:WGRX) gained 28.1% to $0.25 in pre-market trading after jumping 5% on Wednesday.
  • Bumble Inc (NASDAQ:BMBL) gained 26.8% to $3.60 in pre-market trading after the company released its fourth-quarter earnings report and issued a strong first-quarter revenue outlook.
  • Lightwave Logic Inc (NASDAQ:LWLG) gained 25.5% to $6.30 in pre-market trading followed the company's announcement of a development agreement with Israeli integrated circuit manufacturer Tower Semiconductor to integrate its electro-optic polymer-based modulator reference designs into Tower’s PH18 silicon photonics process design kit (PDK).
  • Abivax SA (NASDAQ:ABVX) rose 13.7% to $127.64 in pre-market trading.
  • Battalion Oil Corp (NYSE:BATL) gained 8.7% to $21.14 in pre-market trading amid an escalating U.S., Israel and Iran conflict, which remains the main catalyst.

Losers

  • Netskope Inc (NASDAQ:NTSK) tumbled 15.7% to $10.23 in pre-market trading after posting fourth-quarter results.
  • Golden Sun Technology Group Ltd (NASDAQ:GSUN) dipped 14% to $0.49 in pre-market trading after gaining 12% on Wednesday.
  • VisionSys AI Inc (NASDAQ:VSA) fell 13.4% to $1.10 in pre-market trading.
  • Tantech Holdings Ltd (NASDAQ:TANH) fell 12.6% to $0.90 in pre-market trading after jumping 35% on Wednesday.
  • Scworx Corp (NASDAQ:WORX) declined 12.6% to $0.13 in pre-market trading after jumping 15% on Wednesday. On March 4, SCWorx disclosed a new SaaS and data management agreement with a Southeastern healthcare provider whose integrated delivery network spans over 700 beds across multiple acute care hospitals and outpatient facilities.
  • Acurx Pharmaceuticals Inc (NASDAQ:ACXP) fell 12.4% to $5.28 in pre-market trading after jumping 108% on Wednesday. On Monday, Acurx said it is launching a new clinical trial program for ibezapolstat in patients with recurrent C. difficile infection, or rCDI, while also preparing to advance the drug into Phase 3 international studies for the broader CDI population, subject to funding.
  • Paranovus Entertainment Technology Ltd (NASDAQ:PAVS) dipped 9.7% to $2.06 in pre-market trading after surging 63% on Wednesday.
  • Honda Motor Co Ltd (NYSE:HMC) shares dipped 7.7% to $25.43 in pre-market trading.
  • Astec Industries Inc (NASDAQ:ASTE) fell 6.3% to $52.71 in pre-market trading.
  • UiPath Inc (NYSE:PATH) fell 5.7% to $11.66 in pre-market trading after the company reported fourth-quarter results and announced a new $500m stock repurchase authorization.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.